#Human Milk Oligosaccharides

[nutritionproducts]

What Are Human Milk Oligosaccharides (HMOs)

Human Milk Oligosaccharides (HMOs) are complex sugars found in breast milk, known for supporting a baby's immune system and gut health.

[foodagriculturenews]

The global Human Milk Oligosaccharides (HMO) Market size was valued at USD 199 million in 2022 and is projected to reach USD 556 million by 2027, growing at a CAGR of 22.7% from 2022 to 2027.

[shrutirathi226]

Human Milk Oligosaccharides: Insights from Recent Research and Clinical Trials

Breast milk is a rich source of complex carbohydrates called human milk oligosaccharides (HMOs). After fat and lactose, they are the third most common solid component in human milk, yet they play an important role that goes well beyond simple nourishment. Human Milk Oligosaccharides are important because of their intricate biological roles and complicated structure, which are essential to a baby’s proper growth.

Human Milk Oligosaccharides are only found in human milk, and the makeup of this unique substance changes across people and lactation phases. More than 200 distinct kinds of Human Milk Oligosaccharides exist, and they can have very complicated structures made up of multiple sugar units connected in sophisticated ways. HMOs may perform a variety of tasks that are critical to the health of newborns because of their intricacy.

Serving as prebiotics is one of Human Milk Oligosaccharides main functions. They supply Bifidobacteria and other good gut flora with nourishment, which is essential for the development of a baby’s microbiome. Human Milk Oligosaccharides assist in maintaining a balanced gut flora, which is essential for healthy digestion and immune system performance, by encouraging the growth of these advantageous bacteria.

Human Milk Oligosaccharides have also been demonstrated to have anti-infection properties. They function as fictitious receptors, blocking the attachment of dangerous bacteria to the gut lining. Human Milk Oligosaccharides lessen the chance of infections, including those brought on by gastrointestinal pathogens like E. coli, by taking up these binding sites. This defense system enhances the infant’s general health and wellbeing.

Another major area of study for Human Milk Oligosaccharides is their ability to modulate the immune system. Human Milk Oligosaccharides interact with immune cells and signaling pathways to affect how the baby’s immune system develops. They support the growth of the infant’s innate and adaptive immunity as well as the maturation of the gut-associated lymphoid tissue (GALT). In the early months of life, when the infant’s immune system is still growing, this immunological support is especially important.

Human Milk Oligosaccharides may also be important for the development of cognition and for delaying the onset of chronic illnesses later in life, according to recent studies. Although research in these areas is still ongoing, encouraging first results indicate that Human Milk Oligosaccharides offer advantages beyond their direct impact on health.

The genetic makeup of the mother has an impact on the composition of Human Milk Oligosaccharides, which can differ greatly. Because of this variation, each mother’s milk is specific to the demands of her infant and may provide health advantages that are unique to each individual.

To sum up, Human Milk Oligosaccharides are an essential part of breast milk that have a variety of intricate roles that promote the health of the baby. Their relevance in the early stages of life is highlighted by their roles as prebiotics, immunological modulators, and agents that guard against infections. Human Milk Oligosaccharides importance for baby nutrition and health is becoming more and more clear as research reveals the entire range of advantages they offer.illnesses in later life. Although research in these areas is still ongoing, encouraging first results indicate that Human Milk Oligosaccharides offer advantages beyond their direct impact on health.

[blueweave8]

Human Milk Oligosaccharides Market Analysis, Outlook, Forecast 2023-2030

The Global Human Milk Oligosaccharides (HMO) Market, valued at USD 100.8 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 16.4% during the forecast period from 2024 to 2030, reaching USD 250.1 million by 2030. The Human Milk Oligosaccharides (HMO) market is experiencing rapid growth, driven by increasing awareness of the critical health benefits these complex carbohydrates provide. HMOs, found naturally in human breast milk, play a vital role in infant health by promoting gut health, enhancing immune function, and offering protection against infections. With the rising demand for infant formula that closely replicates the benefits of human milk, HMOs are becoming an essential ingredient in the nutrition industry.

Technological advancements in biotechnology have facilitated the large-scale production of HMOs, making them accessible for a range of applications beyond infant nutrition. These include dietary supplements, functional foods and beverages, and potential uses in medical and personal care products. The market's expansion is further propelled by a growing focus on preventive healthcare and the increasing consumer preference for functional foods that support overall health and well-being.

Growth Drivers

Growing focus on preventive healthcare

The Human Milk Oligosaccharides (HMOs) market is experiencing a surge in demand driven by increasing awareness of their health benefits, particularly in infant nutrition and functional foods. HMOs are naturally occurring complex sugars found in breast milk, known for their ability to support infant health by promoting a healthy gut microbiome, aiding in immune system development, and potentially reducing the risk of infections and allergies.

In infant nutrition, HMOs are being recognized as valuable components that mimic the benefits of breast milk, leading to their inclusion in infant formulas and baby foods. Parents and healthcare professionals are increasingly seeking products containing HMOs to provide optimal nutrition for infants who are not exclusively breastfed.

Challenges

Regulatory hurdles and stringent approval processes

Navigating regulatory hurdles and stringent approval processes presents a significant challenge in the Human Milk Oligosaccharides (HMOs) market. Due to the critical nature of products targeting infants and dietary supplements, regulatory bodies impose rigorous standards to ensure safety, efficacy, and quality. The complexity of HMOs as novel ingredients adds to the challenge, requiring extensive scientific data and clinical studies to support their use in food and nutritional products.

These regulatory hurdles can delay product development timelines, increase costs, and pose barriers to market entry for companies. Companies must invest in comprehensive research, toxicological assessments, and regulatory submissions, often involving multiple regulatory agencies across different regions.

Impact of Escalating Geopolitical Tensions on Global Human Milk Oligosaccharides Market

Escalating geopolitical tensions have a multifaceted impact on the global Human Milk Oligosaccharides (HMOs) market. These tensions can disrupt supply chains, leading to uncertainties in sourcing raw materials and manufacturing processes. International trade restrictions, tariffs, and sanctions imposed during geopolitical conflicts can also hinder the movement of HMO-based products across borders, affecting distribution networks and market access. Furthermore, geopolitical instability may influence consumer confidence and behavior, impacting demand for HMOs in different regions. Economic repercussions of geopolitical tensions, such as currency fluctuations and market volatility, can affect pricing strategies and overall market dynamics. Additionally, regulatory environments may be affected by geopolitical changes, with potential shifts in trade agreements, standards, and import/export regulations. This can create challenges for companies operating in the HMOs market, requiring them to adapt quickly to evolving regulatory landscapes. Moreover, geopolitical tensions can impact investment decisions, research collaborations, and strategic partnerships within the HMOs industry. Uncertainties related to geopolitical stability may lead to cautious approaches by stakeholders, affecting innovation, expansion plans, and market growth opportunities.

Global Human Milk Oligosaccharides Market

Segmental Coverage

Global Human Milk Oligosaccharides Market – By Product

Based on product type, 2'-Fucosyllactose segment is expected to grow in the forecast period as 2'-FL is one of the most abundant and well-studied HMOs naturally present in breast milk, making it highly desirable for infant nutrition and functional food applications. Its structural similarity to the oligosaccharides found in human milk gives it a strong biological relevance and potential health benefits. Secondly, research has highlighted the positive effects of 2'-FL on infant health, including its role in supporting a healthy gut microbiome, enhancing immune system development, and potentially reducing the risk of infections and allergies in infants. These documented health benefits have increased the demand for products containing 2'-FL, such as infant formulas, baby foods, and dietary supplements. Moreover, advancements in biotechnological processes have enabled the production of 2'-FL on a commercial scale, making it more accessible for incorporation into various consumer products. This availability, coupled with growing consumer awareness of HMOs and their benefits, has fueled the growth of the 2'-FL segment in the HMOs market. Additionally, regulatory approvals and endorsements from healthcare professionals further contribute to the prominence of 2'-FL, solidifying its position as a leading growth segment within the global HMOs market.

Global Human Milk Oligosaccharides Market – By End Use Application

The infant nutrition segment is anticipated to experience significant growth in the forecast period due to the natural abundance of Human Milk Oligosaccharides (HMOs) in human breast milk. HMOs play pivotal roles in infant health by fostering a healthy gut microbiome, bolstering immune system development, and facilitating the digestion and absorption of nutrients. As breast milk is considered the gold standard for infant nutrition, manufacturers strive to mimic its composition as closely as possible in infant formula, leading to the inclusion of HMOs. Furthermore, HMOs are believed to offer benefits that extend beyond basic nutrition, such as reducing the risk of infections, allergies, and inflammatory conditions in infants. This added health value drives parents and healthcare professionals to prefer infant formulas supplemented with HMOs, enhancing the market demand.

Furthermore, research and clinical studies continue to demonstrate the positive impact of HMOs on infant health outcomes, further bolstering their demand in infant formula. Regulatory approvals and endorsements from health authorities also contribute to the growing acceptance and adoption of HMO-enriched infant formulas, solidifying their position as a sought-after component in early childhood nutrition.                                                                    

Global Human Milk Oligosaccharides Market – By Form

Based on Form, the Amorphous Powder is expected to grow in the forecast period owing to its superior solubility and bioavailability. Amorphous Powder has a non-crystalline structure, which makes it easier to dissolve in liquids, such as infant formula, beverages, or dietary supplements. This property enhances its usability and allows for better incorporation into various food and nutritional products without compromising on texture or taste.

Additionally, Amorphous Powder typically exhibits improved stability and shelf-life compared to Crystalline Powder, making it a preferred choice for manufacturers seeking long-term product stability and quality. The enhanced solubility and stability of Amorphous Powder contribute to its higher demand in the market, especially in applications where quick dissolution, effective delivery, and product longevity are essential factors influencing consumer satisfaction and product performance.

Contact Us:

BlueWeave Consulting & Research Pvt Ltd

+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662

info@blueweaveconsulting.com

[chemicalresearchupdates]

Human Milk Oligosaccharides Market Growth: Key Players and Competitive Landscape

Human Milk Oligosaccharides (HMOs) are a group of complex carbohydrates that are naturally found in human breast milk. These compounds play a crucial role in supporting the health and development of infants. HMOs are not digested by the infant, but instead serve as a source of nutrition for beneficial bacteria in the baby's gut, promoting the growth of a healthy microbiome.

The Human Milk Oligosaccharides market has seen significant growth in recent years, driven by growing awareness of the health benefits associated with breastfeeding and increasing demand for infant formula fortified with HMOs. As more research sheds light on the various health advantages of HMOs, both consumers and the baby food industry have shown a keen interest in these compounds.

The market for Human Milk Oligosaccharides is witnessing robust growth due to the rising awareness among parents regarding the importance of breastfeeding and the nutritional advantages it offers to infants. Moreover, the demand for infant formula enriched with HMOs has surged, as it aims to mimic the benefits of breast milk for babies who are not exclusively breastfed. This has led to a notable increase in the production and availability of HMO-fortified infant formula products.

The Human Milk Oligosaccharides market industry is marked by several trends that are shaping its development. One prominent trend is the increasing emphasis on research and development to understand the specific functions and potential therapeutic applications of various HMOs. This research has highlighted the role of HMOs in supporting the infant immune system, preventing infections, and contributing to cognitive development.

Another notable trend in the HMO market is the exploration of their potential use in other products beyond infant formula. Some companies are incorporating HMOs into dietary supplements for adults, recognizing their prebiotic and health-promoting properties. Additionally, there is a growing focus on sustainable production methods for HMOs, which align with the broader trend of environmental responsibility in the food industry.

In conclusion, the Human Milk Oligosaccharides market is witnessing substantial growth due to increased awareness of the nutritional benefits of HMOs for infants. This growth is driven by the demand for HMO-fortified infant formula and ongoing research that continues to unveil the diverse functions and potential applications of these complex carbohydrates. As the industry evolves, it is likely to witness further innovation and expansion, with HMOs potentially finding their way into various products designed to support human health and well-being.

[futuretonext]

The Global Human Milk Oligosaccharides (HMO) Market is projected to grow at around 21.75% CAGR during the forecast period, i.e., 2023-28. The growth of the market would be propelled mainly by increasing concerns among consumers regarding health & wellness, growing awareness about the importance of optimal nutrition for infants as well as the benefits of HMOs. Besides, the ever-increased focus on infant health & development, coupled with technological advancements in HMO production methods, are other prominent aspects expected to drive the market in the future.

[maaarine]

Eve: How the Female Body Drove 200 Million Years of Human Evolution (Cat Bohannon, 2023)

"So, let’s concede that agriculture was crucial to the rise of cities.

But then let’s ask the other question: not just who’s feeding the adults, but who’s feeding the babies in this growing population, and how that affects how they are being made in the first place.

After all, female bodies are the literal engineers of urban populations.

Agriculture might have helped an abundance of bodies to come together, exploiting all those urban niches, but we should also assume that new problems arose from such close contact: widespread infections, for one, the legacy of which we can see in the oligosaccharides of human milk.

We also know that from the dawn of recorded civilization human beings have employed wet nurses.

These women, paid or enslaved to breast-feed others’ babies, enabled population booms. (…)

Breast-feeding, in other words, is a very predictable sort of birth control.

It is an imperfect birth control, with a far lower success rate than our more modern interventions (condoms, hormones, bits of copper inserted in the womb), but nonetheless breast-feeding is Nature’s Pill.

Morgie didn’t have the energy to nurse more than one set of pups at a time; it would have been suicide not to space out her pregnancies.

For this reason, the genetic mutations that allowed birth spacing were favored.

Once primates evolved to have fewer offspring at a time, that evolutionary legacy had a strong hold.

Generally speaking, our ovaries stay quiet while our breasts are at work.

So, imagine what happens to a city’s population when you have a large percentage of its mothers employing wet nurses.

In principle, that would reduce a woman’s mean birth interval significantly, from 4.1 years to as little as 1.3 years.

Gestation takes about 9 months. You’d be pregnant pretty much all the time.

Meanwhile, wet nurses wouldn’t be pregnant as often as you, but because breast-feeding is an imperfect ovulation suppressor, they wouldn’t be entirely un-pregnant, either.

Many would have their own children, some of them born immediately before yours and some born while yours are still nursing.

Many women are perfectly capable of nursing more than two children.

These so-called super producers—we can assume such women would be more likely to find steady employment as a wet nurse—could be nursing three or four kids at a time without much increase in infant mortality.

It’s not hard to imagine how the population of an ancient city could explode under such circumstances."

[esuplianusha]

Similac 360 Total Care Sensitive Infant Formula

Supporting Your Baby’s Sensitive Tummy

Overview of Similac 360 Total Care

Similac 360 Total Care Sensitive Infant Formula is specifically designed to address fussiness and gas that can arise from lactose sensitivity in infants. This advanced formula offers a blend of nutrients that closely resembles breast milk, making it a suitable choice for parents seeking a gentle yet comprehensive feeding solution.

Key Benefits for Lactose Sensitivity

One of the standout features of Similac 360 Total Care Sensitive Infant Formula is its formulation tailored to reduce fussiness and gas caused by lactose sensitivity. This is achieved through a carefully crafted formula that is easy on your baby’s delicate digestive system, promoting a more comfortable feeding experience.

Inclusion of 5 HMO Prebiotics

Similac 360 Total Care Sensitive Infant Formula contains 5 HMO (Human Milk Oligosaccharides) prebiotics, which are crucial for supporting your baby's developing digestive system. These prebiotics are designed to enhance the growth of beneficial gut bacteria, aiding in better digestion and overall gut health.

Non-GMO Formula

For those concerned about genetically modified organisms, Similac 360 Total Care Sensitive Infant Formula is proudly non-GMO. This ensures that the formula is made without genetically modified ingredients, providing peace of mind to parents who prioritize natural and safe feeding options for their infants.

Convenient Packaging

The formula comes in a 20.1-ounce tub, which is both convenient and practical for regular use. Similac 360 Total Care Sensitive Infant Formula is easy to store and measure, making it straightforward for parents to prepare the right amount of formula for their baby’s needs.

Promoting Healthy Development

Similac 360 Total Care Sensitive Infant Formula is designed not only to address sensitivity issues but also to support overall growth and development. The formula includes essential nutrients that are vital for your baby’s brain development, immune system, and physical growth, ensuring comprehensive care.

Easy Preparation

With Similac 360 Total Care Sensitive Infant Formula, preparation is made simple and efficient. The powder formula mixes easily with water, allowing for quick and hassle-free feeding, which is especially beneficial during late-night feedings or when on-the-go.

Supports Balanced Nutrition

By choosing Similac 360 Total Care Sensitive Infant Formula, you are providing your baby with balanced nutrition that supports their specific needs. This formula is designed to offer a complete nutritional profile, helping to ensure that your baby receives all the essential vitamins and minerals required for healthy development.

Trust in Quality

Similac 360 Total Care Sensitive Infant Formula is manufactured with high-quality standards to ensure safety and effectiveness. Parents can trust that this formula adheres to stringent regulations, providing a reliable feeding option for their infants.

Conclusion

For parents dealing with lactose sensitivity and seeking a formula that offers both comfort and comprehensive nutrition, Similac 360 Total Care Sensitive Infant Formula provides an excellent solution. With its blend of prebiotics, non-GMO ingredients, and essential nutrients, this formula supports a happier and healthier feeding experience for your baby.

[nutritionproducts]

Human Milk Oligosaccharides (HMOs) are complex sugars found in breast milk that play a vital role in shaping the infant's gut microbiota, supporting immune development, and protecting against infections. They are not digested by the infant but serve as food for beneficial bacteria in the gut, promoting a healthy microbiome.

[foodagriculturenews]

The global Human Milk Oligosaccharides (HMO) Market size was valued at USD 199 million in 2022 and is projected to reach USD 556 million by 2027, growing at a CAGR of 22.7% from 2022 to 2027.

[memoriae-lectoris]

Breast milk is rich in over 200 nutrients, including human milk oligosaccharides, or HMOs. Yet babies can’t digest HMOs; they’re only there to feed a special microbe in our gut called B. infantis.

When this microbe digests HMOs, it releases nutrients in the form of proteins, which babies can digest. These include anti-inflammatory proteins that coat the gut and calibrate our immune system.

[waquasuniverse]

Human Milk Oligosaccharides Market To Reach $732.23Mn By 2030

The global human milk oligosaccharides market size is expected to reach USD 732.23 million by 2030, registering a CAGR of 13.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is primarily driven by the rising demand for dietary supplements and an increasing awareness among consumers regarding the significance of gut health. Human milk oligosaccharides…

[globalgrowthinsights]

Pvc Cling Film Market Trends, Demand & Future Scope till 2032

Pvc Cling Film Market provides in-depth analysis of the market state of Pvc Cling Film manufacturers, including best facts and figures, overview, definition, SWOT analysis, expert opinions, and the most current global developments. The research also calculates market size, price, revenue, cost structure, gross margin, sales, and market share, as well as forecasts and growth rates. The report assists in determining the revenue earned by the selling of this report and technology across different application areas.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Pvc Cling Film in these regions till the forecast period

North America

Middle East and Africa

Asia-Pacific

South America

Europe

Key Attentions of Pvc Cling Film Market Report:

The report offers a comprehensive and broad perspective on the global Pvc Cling Film Market.

The market statistics represented in different Pvc Cling Film segments offers complete industry picture.

Market growth drivers, challenges affecting the development of Pvc Cling Film are analyzed in detail.

The report will help in the analysis of major competitive market scenario, market dynamics of Pvc Cling Film.

Major stakeholders, key companies Pvc Cling Film, investment feasibility and new market entrants study is offered.

Development scope of Pvc Cling Film in each market segment is covered in this report. The macro and micro-economic factors affecting the Pvc Cling Film Market

Advancement is elaborated in this report. The upstream and downstream components of Pvc Cling Film and a comprehensive value chain are explained.

Browse More Details On This Report at @https://www.globalgrowthinsights.com/market-reports/pvc-cling-film-market-100586

 Global Growth Insights

Web: https://www.globalgrowthinsights.com

Our Other Reports:

Global Mining Explosives MarketMarket Share

Global Rolling Luggage Bags MarketMarket Growth

Floating Production Storage and Offloading (FPSO) MarketMarket

Fundus Cameras MarketMarket Share

Collagen & Gelatin MarketMarket Growth Rate

RFID Printer MarketMarket Forecast

Global Sheet Metal Fabrication Services MarketMarket Size

Online Therapy Services MarketMarket Growth

Dairy Alternative Beverages MarketMarket Analysis

Memory Cards MarketMarket Size

Global CAR T-Cell Therapy MarketMarket Share

Global PCTFE MarketMarket Growth

TOPCon Solar Cell MarketMarket

NGOs and Charitable Organizations MarketMarket Share

Broadband Network Gateway (BNG) MarketMarket Growth Rate

Hyaluronic Acid Based Dermal Fillers MarketMarket Forecast

Global Crypto Asset Management MarketMarket Size

Narrowband IoT (NB-IoT) Chipset MarketMarket Growth

Internet of Things IoT Develop Services MarketMarket Analysis

AI-assisted Diagnosis MarketMarket Size

Global Internet of Things in Retail MarketMarket Share

Global Ginger MarketMarket Growth

Ballast Water Management MarketMarket

Laser Treatment Devices of Varicose Veins MarketMarket Share

LABSA MarketMarket Growth Rate

Human Milk Oligosaccharides MarketMarket Forecast

Global Solar Microinverter and Power Optimizer MarketMarket Size

Digital Experience Platform (DXP) MarketMarket Growth

Glioblastoma Multiforme Treatment MarketMarket Analysis

Frameless Brushless DC Motors MarketMarket Size

Global HSC Milling Machines MarketMarket Share

Global Mobile AB Testing MarketMarket Growth

Gummy Vitamins MarketMarket

Gastrointestinal Stent MarketMarket Share

Automotive HUD MarketMarket Growth Rate

Central Tire Inflation System (CTIS) MarketMarket Forecast

Global Continuous Mixed Flow Dryer MarketMarket Size

Homemade Facial Mask Machine MarketMarket Growth

Public Sector Software MarketMarket Analysis

Private Charging Station for Electric Vehicle MarketMarket Size

[marketsndata]

Global Galacto-oligosaccharides Market Assessment, Opportunities and Forecast, 2016-2030F

Global galacto-oligosaccharides market size was recorded at 50.94 kilotons in 2022, which is expected to grow to 78.18 kilotons in 2030 with a CAGR of 5.5%, during the forecast period between 2023 and 2030. The galacto-oligosaccharides market is influenced by several key drivers that have contributed to its growth and prominence. One of the primary drivers is the increasing awareness of the importance of gut health. Consumers are now more conscious of how a healthy gut microbiome can impact overall well-being, which has led to a higher demand for prebiotic ingredients, like GOS.

The rising popularity of functional foods and beverages is another significant driver as consumers seek products that offer health benefits beyond basic nutrition, and GOS is often used in these functional items. Additionally, the use of GOS in infant formula due to its similarity to human milk oligosaccharides (HMOs) has propelled demand in the infant nutrition segment.

Moreover, the development of functional beverages, including probiotic and prebiotic drinks, has expanded the use of GOS. These beverages have gained popularity for their potential to enhance digestive health. Conclusively, Research and clinical studies have played a significant role in advancing the GOS market as ongoing research into the health benefits of GOS and positive results from clinical studies have contributed to the growing reputation and demand for this ingredient.

Demand for Pet Feed to Increase the use of Galacto-oligosaccharides

The utilization of Galacto-oligosaccharides (GOS) in pet feed is gaining prominence, driven by the growing recognition of the significance of pet health and nutrition. GOS offers a range of benefits for pets, with a primary focus on enhancing their digestive health, and supports the pet’s gut microbiome, aids in digestion, and diminishing the occurrence of gastrointestinal issues. Moreover, GOS has demonstrated its potential in fortifying the immune system of pets, bolstering their resistance to diseases and serve to mitigate allergic reactions in pets, thus establishing itself as a valuable ingredient for the management of common pet allergies.

For instance, Nestlé Purina PetCare Co. allocated an investment of USD 182 million to expand its manufacturing facility for pet care products in King William County, Virginia, the United States. Expansion of manufacturing and strong demand for pet feed to strengthen the Galacto-oligosaccharides globally.

Sample Report- https://www.marketsandata.com/industry-reports/galacto-oligosaccharides-market/sample-request

Increasing Consumption of Prebiotics Drinks to Heighten Galacto-oligosaccharides Demand

Galacto-oligosaccharides play a pivotal role in the dietary supplements industry, where it is widely promoted for its potential health benefits, particularly in supporting gut health. The increasing focus on digestive well-being has driven significant demand for GOS within the dietary supplements sector. Moreover, the surge in the dietary supplements industry has been accompanied by the development of functional beverages. It includes a range of products like probiotic and prebiotic drinks and foods that aim to enhance overall health through improved gut microbiome balance.

For instance, during July 2023, FHIRST Living Soda entered the beverage market, marking the pioneering all-natural, sugar-free drink that uniquely blends probiotics and prebiotics to support gut health. The rise in launches of functional foods across the globe increases the demand for galacto-oligosaccharides.

Rising Integration of Galacto-oligosaccharides in Pharmaceutical Application to Improve Demand

GOS has been the subject of research focused on its potential to mitigate symptoms associated with gastrointestinal disorders, including conditions like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). GOS fosters the proliferation of beneficial gut bacteria and has shown promise and helps in enhancing gut health and diminishing associated symptoms. In addition to addressing gastrointestinal disorders, it is used for managing diarrhea. Therefore, it is a featured ingredient in specific pharmaceutical products, such as oral rehydration solutions, designed to alleviate diarrhea, with a particular focus on its efficacy in infants and young children.

For instance, during Q1 of 2023, Johnson & Johnson reported impressive results in their sales experiencing a robust upswing of nearly 10 percent in the United States, reaching a total of USD 12.52 billion. The upsurge in sales of pharmaceuticals is expected to contribute to rising demand for GOS.

Impact of COVID-19

The galacto-oligosaccharides market experienced significant disruption due to the outbreak of COVID-19. Although the pandemic had a relatively milder impact on the food and beverage industry compared to other sectors, it severely affected the industry’s global supply chain, constraining its growth potential. The shift in consumer behavior during this time had a detrimental effect on purchasing patterns, resulting in several challenges, including operational halts, hindrances to business expansion, and suspended activities. However, on the other hand, the lockdown heightened demand for GOS in few applications as the need for pet feed and prebiotic drinks increased during the pandemic.

Key Outlook

·         A huge percentage of the population of people across the globe is lactose intolerant, which is a major restrain to the market. However, the development of plant-based GOS will witness a consumption increase within this population.

·         The ongoing research of GOS in pharmaceuticals along with growing awareness of gut health will improve the demand for galacto-oligosaccharides marketglobally.

Global Galacto-oligosaccharides Market: Report Scope

“Galacto-oligosaccharides Market Assessment, Opportunities and Forecast, 2016-2030F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of global galacto-oligosaccharides market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, COVID-19 impact, opportunities, and forecast between 2023 and 2030. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.

Click here for full report- https://www.marketsandata.com/industry-reports/galacto-oligosaccharides-market

Contact

Mr. Vivek Gupta 5741 Cleveland street, Suite 120, VA beach, VA, USA 23462 Tel: +1 (757) 343–3258 Email: info@marketsandata.com Website: https://www.marketsandata.com

[futuretonext]

The Global Human Milk Oligosaccharides (HMO) Market is projected to grow at around 21.75% CAGR during the forecast period, i.e., 2023-28. The growth of the market would be propelled mainly by increasing concerns among consumers regarding health & wellness, growing awareness about the importance of optimal nutrition for infants as well as the benefits of HMOs. Besides, the ever-increased focus on infant health & development, coupled with technological advancements in HMO production methods, are other prominent aspects expected to drive the market in the future.